[{"type": "title", "data": "ED Buprenorphine-Naloxone (Suboxone) (Module)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Discharge Criteria: when patient is comfortable and/or maximum dose of buprenorphine-naloxone is reached", "value": ""}, {"type": "category", "data": "Status"}, {"type": "note", "data": "If patient is not a candidate for immediate initiation in ED (not in sufficient withdrawal), provide take-home buprenorphine-naloxone if available", "value": ""}, {"type": "note", "data": "Take home buprenorphine-naloxone kit is not intended for patients starting therapy in the ED", "value": ""}, {"type": "note", "data": "Buprenorphine-naloxone initiation requires an addiction consult in the following cases:  \n-Altered LOC/intoxication   \n-Pregnancy  \n-Liver dysfunction   \n-Respiratory distress  \n-On prescribed opioids for pain management  \n-On opioid agonist therapy e.g. methadone or sustained release oral morphine", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Clinical Opiate Withdrawal Scale", "value": "checked"}, {"type": "sentence", "data": "Pre-initiation monitoring: Complete COWS at first sign of opioid withdrawal. Assess patient q2h until COWS is 9, then q1h until COWS is greater than 12. On initiation monitoring: q30min for 2 doses or times"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "For sites without buprenorphine-naloxone take home kit, provide patients receiving home induction with a prescription: buprenorphine-naloxone 2 mg-0.5 mg tab, dispense 18 tabs for home induction. Day 1: 2 mg, sublingual, q1h, PRN up to maximum of 6 tabs (12 mg). Day 2: 12 mg sublingual. Day 3: 16 mg, sublingual, qdaily. Dispense all tabs as carries", "value": ""}, {"type": "note", "data": "Provide Buprenorphine-Naloxone take home kit if COWS less than or equal to 12 and not eligible for induction in the ED ", "value": ""}, {"type": "order", "data": "buprenorphine-naloxone 2 mg-0.5 mg tab (dosed as buprenorphine)", "value": ""}, {"type": "sentence", "data": "2 mg, sublingual, once, drug form: kit, Dispense Take Home Medication, Dispense qty: 18 tab"}, {"type": "note", "data": "For patient receiving buprenorphine-naloxone in ED:", "value": ""}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "Notify provider when COWS score greater than 12"}, {"type": "note", "data": "Provider MUST verify COWS is greater than 12 prior to first dose", "value": ""}, {"type": "order", "data": "buprenorphine-naloxone 2 mg-0.5 mg tab (dosed as buprenorphine)", "value": "checked"}, {"type": "sentence", "data": "2 mg, sublingual, once, drug form: tab"}, {"type": "order", "data": "buprenorphine-naloxone 2 mg-0.5 mg tab (dosed as buprenorphine)", "value": "checked"}, {"type": "sentence", "data": "2 mg, sublingual, q1h, PRN other (see comment), order duration: 24 hour, drug form: tab"}, {"type": "category", "data": "Non Categorized"}, {"type": "note", "data": "Follow up for Discharge Planning: Write discharge prescription for total dose of buprenorphine-naloxone received in ED as once a day x number of days until RAAC or local opioid agonist therapy clinic", "value": ""}]
